West Pharmaceutical Services, Inc. Stock Sao Paulo
Stocks
W2ST34
BRW2STBDR007
Medical Equipment, Supplies & Distribution
|
Market Closed -
Sao Paulo
13:53:32 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 49.25 BRL | -2.36% |
|
-.--% | +20.83% |
| 10-30 | Stephens Adjusts West Pharmaceutical Services Price Target to $490 From $450 | MT |
| 10-30 | Deutsche Bank Adjusts West Pharmaceutical Services PT to $450 From $420, Maintains Buy Rating | MT |
| Market Cap | 28.74B 156B 25.74B 23.68B 21.46B 40.11B 2,729B 40.86B 282B 113B 1,436B 108B 106B 4,528B | P/E 2026 * |
48.1x | P/E 2027 * | 40.2x |
|---|---|---|---|---|---|
| Enterprise Value | 28.13B 153B 25.2B 23.18B 21B 39.26B 2,671B 39.99B 276B 111B 1,405B 106B 103B 4,432B | EV / Sales 2026 * |
8.23x | EV / Sales 2027 * | 7.7x |
| Free-Float |
91.94% | Yield 2026 * |
0.23% | Yield 2027 * | 0.24% |
Last Transcript: West Pharmaceutical Services, Inc.
| 1 day | -2.36% | ||
| 3 months | -3.90% | ||
| 6 months | +14.00% | ||
| Current year | +20.83% |
| Current year | 34.5 |  | 53.25 |
| 1 year | 34.5 | | 53.25 |
| 3 years | 32.64 | | 60 |
| 5 years | 30.7 | | 75.51 |
| 10 years | 30.7 | | 75.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michel Lagarde
CEO | Chief Executive Officer | 52 | 2026-08-30 |
Robert McMahon
DFI | Director of Finance/CFO | 57 | 2025-08-03 |
Devesh Mathur
CTO | Chief Tech/Sci/R&D Officer | - | 2025-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Buthman
BRD | Director/Board Member | 65 | 2011-01-31 |
Douglas Michels
BRD | Director/Board Member | 69 | 2011-03-06 |
William Feehery
BRD | Director/Board Member | 56 | 2012-02-11 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.36% | -.--% | - | - | 28.74B | |
| +1.56% | +2.41% | -14.82% | +14.19% | 184B | |
| -6.38% | -4.98% | -20.90% | +11.15% | 112B | |
| -0.59% | +1.18% | +6.12% | +37.97% | 118B | |
| +3.42% | +1.71% | -42.32% | +9.52% | 94.58B | |
| +0.09% | -0.05% | -3.04% | +78.44% | 63.13B | |
| -0.46% | +0.42% | +8.19% | +82.97% | 55.66B | |
| -0.23% | -0.52% | +10.31% | -21.19% | 53.9B | |
| -4.30% | -1.64% | -12.30% | +39.06% | 43.42B | |
| +0.58% | +2.00% | -1.07% | -6.43% | 34.68B | |
| Average | -0.87% | +0.06% | -7.76% | +27.30% | 84.36B | |
| Weighted average by Cap. | -0.56% | +0.23% | -10.66% | +25.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.42B 18.56B 3.06B 2.82B 2.55B 4.77B 325B 4.86B 33.58B 13.48B 171B 12.83B 12.56B 538B | 3.62B 19.64B 3.24B 2.98B 2.7B 5.05B 343B 5.14B 35.53B 14.26B 181B 13.57B 13.28B 570B |
| Net income | 659M 3.58B 590M 543M 492M 919M 62.57B 937M 6.47B 2.6B 32.91B 2.47B 2.42B 104B | 722M 3.92B 647M 595M 539M 1.01B 68.59B 1.03B 7.1B 2.85B 36.08B 2.71B 2.65B 114B |
| Net Debt | -609M -3.31B -546M -502M -455M -850M -57.85B -866M -5.99B -2.4B -30.43B -2.29B -2.24B -95.97B | -909M -4.94B -814M -749M -679M -1.27B -86.32B -1.29B -8.93B -3.59B -45.41B -3.41B -3.34B -143B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- WST Stock
- W2ST34 Stock
Select your edition
All financial news and data tailored to specific country editions
